Responses induced by tacrine in neuronal
β
Giancarlo V. De Ferrari; Rommy von Bernhardi; Frances H. CalderΓ³n; Sandra C. Luz
π
Article
π
1998
π
John Wiley and Sons
π
English
β 513 KB
Alzheimer's disease (AD) is associated with a reduction in cholinergic activity as a result of specific neuronal loss. Current potential treatments for the disease include both cholinomimetic drugs and anticholinesterase inhibitors. One of the drugs approved by the FDA is tacrine (9-amine-1,2,3,4 te